![](/images/graphics-bg.png)
Antivascular Therapy for Epithelial Ovarian Cancer
Joint Authors
Duhoux, Francois P.
Machiels, Jean-Pascal
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-16, 16 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-12-23
Country of Publication
Egypt
No. of Pages
16
Main Subjects
Abstract EN
Ovarian cancer is the fifth largest cancer killer in women.
Improved understanding of the molecular pathways implicated in the pathogenesis of ovarian cancer has led to the investigation of novel targeted therapies.
Ovarian cancer is characterized by an imbalance between pro- and antiangiogenic factors in favor of angiogenesis activation.
Various antivascular strategies are currently under investigation in ovarian cancer.
They can schematically be divided into antiangiogenic and vascular-disrupting therapies.
This paper provides a comprehensive review of these new treatments targeting the tumor vasculature in this disease.
Promising activities have been detected in phase II trials, and results of phase III clinical trials are awaited eagerly.
American Psychological Association (APA)
Duhoux, Francois P.& Machiels, Jean-Pascal. 2009. Antivascular Therapy for Epithelial Ovarian Cancer. Journal of Oncology،Vol. 2010, no. 2010, pp.1-16.
https://search.emarefa.net/detail/BIM-466859
Modern Language Association (MLA)
Duhoux, Francois P.& Machiels, Jean-Pascal. Antivascular Therapy for Epithelial Ovarian Cancer. Journal of Oncology No. 2010 (2010), pp.1-16.
https://search.emarefa.net/detail/BIM-466859
American Medical Association (AMA)
Duhoux, Francois P.& Machiels, Jean-Pascal. Antivascular Therapy for Epithelial Ovarian Cancer. Journal of Oncology. 2009. Vol. 2010, no. 2010, pp.1-16.
https://search.emarefa.net/detail/BIM-466859
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-466859